SUSANNE SMITHSON: Open Payments
NPI 1851874069 · BOYNTON BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,356 in 75 payments from 18 companies in 2025. Trend: 2023 $499 · 2024 $1,309 · 2025 $1,356
Food & beverage: $1,356
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $214 |
| AstraZeneca Pharmaceuticals LP | 10 | $206 |
| Novo Nordisk Inc | 15 | $184 |
| Lilly USA, LLC | 9 | $172 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $149 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $64 |
| Amgen Inc. | 3 | $56 |
| Astellas Pharma US Inc | 2 | $49 |
| Optinose US, Inc. | 2 | $46 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $39 |
Products named: MOUNJARO, CAPLYTA, AIRSUPRA, Wegovy, VRAYLAR, QULIPTA, Kerendia, FARXIGA.
Industry payments across FL — which companies pay providers there.
